David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

It started with uncomfortable contact lenses

Written by on July 13, 2021 in My Rosacea Story, Ocular Rosacea with 1 Comment
It started with uncomfortable contact lenses

This account of a struggle with getting diagnosed and then dealing with ocular rosacea is worth a read. The struggle is ongoing and we wish you all the best Darelle. Ocular Rosacea Is A Real Thing, And It Sucks My struggle with ocular rosacea began 18 months ago, when I first noticed some discomfort with […]

Continue Reading

Epsolay gets boost from Galderma deal

Written by on July 1, 2021 in Acne Treatments, Epsolay, Galderma with 0 Comments
Epsolay gets boost from Galderma deal

The yet to be approved `encapsulated’ Benzoyl Peroxide 5% Cream known as Epsolay has received a huge promotional boost after the rosacea heavyweight Galderma announced a 5 year exclusive license for the US market. Having the backing of a significant licensing deal from Galderma behind them is good news for the owners of Epsolay. The […]

Continue Reading

Teva Generics announces Generic Soolantra

Teva Generics announces Generic Soolantra

Teva Generics has announced that they are now selling a generic version of Soolantra, branded as Ivermectin Cream 1%. This generic formulation of Ivermectin is indicated for the treatment of inflammatory lesions of rosacea – that is the papules and pustules common to rosacea sufferers. Teva Announces the U.S. Launch of its Generic Version of […]

Continue Reading

Soolantra on eyelids for ocular rosacea?

Soolantra on eyelids for ocular rosacea?

The following article was written by Eric Schmid. Feel free to leave your thoughts in the comments below. This topic was also covered by Rosacea News in 2018 – Soolantra for Ocular Rosacea Is Soolantra, spread on eye lids, a good therapy for dry eye, blepharitis, or ocular rosacea? There is a well-known therapy for […]

Continue Reading

Oracea prescriptions grew 110% over 3 years

Written by on April 7, 2021 in Oracea (40mg doxycycline), prescriptions with 1 Comment
Oracea prescriptions grew 110% over 3 years

An interesting graphic emerged from a recent presentation from Menlo Therapeutics, the owners of the recently approved rosacea treatment Zilxi. Menlo quote from statistics showing the typical growth of rosacea prescription sales 1 year and 3 years after a product is approved. Oracea Sales Increasing Here you can see that Oracea is the stand out […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.